send to a friend by email

JPH posts net income of $3.00 million in H1 2023

2023-08-13

According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the first half of 2023, Net profit after tax of the period reached 3,001,271 USD Compared with Net profit after tax 2,303,245 USD for 2022, a net increase in profit of 30.31%.Total assets of the company reached 84,571,128 USD compared with total assets of 83,723,210 USD at the end of year 2022, a net increase of 1.01%.Total liabilities of the company reached 19,708,238 USD compared with total liabilities of 18,491,908 USD at the end of year 2022, a net increase of 6.57%. Net ownership equity of the company reached 64,862,890 USD (Including Non-Controlling Interests of 977,584 USD) compared with total owner equity of 65,231,302 USD (Including Non-Controlling Interests of 964,992 USD) at the end of year 2022, a net decrease of 0.56%.